Pregled po CROSBI profilu: Marko Skelin (CROSBI Profil: 1067, MBZ: 378932)
Pronađeno 54 radova
-
1.Krečak, Ivan; Pivac, Ljerka; Lucijanić, Marko; Skelin, MarkoPolypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms // Biomedicines, 11 (2023), 5; 1301, 16 doi:10.3390/biomedicines11051301 (međunarodna recenzija, članak, znanstveni)
-
2.Krečak, Ivan; Čeko, Monika; Nižetić, Karla; Čubrić, Eva; Županović, Mediana; Skelin, Marko; Lucijanić, MarkoHematocrit to hemoglobin ratio (HHR) may improve prognostication in patients with pulmonary embolism // Scandinavian Journal of Clinical and Laboratory Investigation, 83 (2023), 3; 200-203 doi:10.1080/00365513.2023.2191334 (međunarodna recenzija, članak, znanstveni)
-
3.Dedić Plavetić, Natalija; Dugonjić Okroša, Ana; Silovski, Tajana; Jović Zlatović, Josipa; Jajac Bručić, Lana; Skelin, Marko; Mucalo, IvaInfluence of ovarian function supression on quality of life in breast cancer survivors during adjuvant endocrine therapy. // Journal of Clinical Oncology
Chicago (IL), Sjedinjene Američke Države, 2023. 560, 1 doi:10.1200/JCO.2023.41.16_suppl.560 (poster, međunarodna recenzija, sažetak, znanstveni) -
4.Dugonjić Okroša, A.; Silovski, T.; Dedić Plavetić, N.; Jović Zlatović J.; Jajac Bručić, L.; Skelin, M.; Mucalo, I.INFLUENCE OF OVARIAN FUNCTION SUPRESSION ON QUALITY OF LIFE IN BREAST CANCER SURVIVORS ON ADJUVANT ENDOCRINE THERAPY // ASCO 2023 AMERICAN SOCIETY OF CLINICAL ONCOLOGY
Chicago (IL), Sjedinjene Američke Države, 2023. str. /-/ (poster, međunarodna recenzija, sažetak, znanstveni) -
5.Skelin, Marko; Šarčević, David; Lešin Gaćina, Dina; Mucalo, Iva; Dilber, Ivo; Javor, EugenThe effect of PARP inhibitors in homologous recombination proficient ovarian cancer: meta- analysis // Journal of chemotherapy, 34 (2023), 4; 1-8 doi:10.1080/1120009X.2022.2073161 (međunarodna recenzija, članak, znanstveni)
-
6.Starčević, Dora; Pranić, Shelly; Pinjatela, Jerolima; Skelin, Marko; Mudnić, IvanaANTIBIOTIC THERAPY IN THE COVID-19 PANDEMIC: RETROSPECTIVE COHORT STUDY OF PATIENTS HOSPITALIZED AT THE UNIVERSITY HOSPITAL OF SPLIT // Final programme and abstracts from the 10th Croatian Congress of Pharmacology and the 1st Croatian Congress of Clinical Pharmacology with International Participation
Opatija, Hrvatska, 2022. str. 224-224 (poster, međunarodna recenzija, sažetak, stručni) -
7.Krečak, Ivan; Nižetić, Karla; Čeko, Monika; Skelin, Marko; Lucijanić, MarkoHigher estimated plasma volume status may be associated with an inferior survival in patients with pulmonary embolism // International journal of laboratory hematology, 45 (2022), 2; e32-e35 doi:10.1111/ijlh.13982 (međunarodna recenzija, pismo uredniku, znanstveni)
-
8.Jović Zlatović, J.; Bevanda, M.; Skelin, M.; Telesmanić Dobrić, V.; Curić, Z.; Marijanović, I.; Grubisić-Čabo, F.; Krečak, I.; Tomić, S.; Kralik, K.; Omrčen, T.P-206 Association between primary tumor site of colorectal cancer and RAS/BRAF mutational status with venous thromboembolism: A retrospective- prospective cohort study from 3 Croatian oncology centers // Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022
Barcelona, Španjolska: Elsevier BV, 2022. str. S322-S323 doi:10.1016/j.annonc.2022.04.296 (poster, međunarodna recenzija, sažetak, stručni) -
9.Krečak, Ivan; Babić, Gordan; Skelin, MarkoScurvy // Acta dermatovenerologica Croatica, 30 (2022), 1; 59-60 (međunarodna recenzija, pismo, znanstveni)
-
10.Krečak, Ivan; Celić-Bunikić, Sandra; Skelin, Marko; Lucijanić, Marko; Verstovsek, Srdan; Kušec, RajkoConcomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate // Annals of hematology, 101 (2022), 8; 1885-1886 doi:10.1007/s00277-022-04839-2 (međunarodna recenzija, prikaz, znanstveni)
-
11.Javor, Eugen; Hauser, Goran; Skelin, MarkoTherapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases // JAMA. Journal of the American Medical Association, 327 (2022), 15; 1505-1505 doi:10.1001/jama.2022.2935 (međunarodna recenzija, pismo uredniku, znanstveni)
-
12.Skelin, Marko; Katić, Josip; Šarčević, David; Rahelić, Dario; Lucijanić, Marko; Rešić, Arnes; Puljević, Mislav; Javor, EugenComparison of media and academic attention of recently published positive and neutral or negative randomized cardiovascular clinical trials // Reviews in Cardiovascular Medicine, 23 (2022), 1; 31, 7 doi:10.31083/j.rcm2301031 (međunarodna recenzija, članak, znanstveni)
-
13.Jambrosic Sakoman, A; Jendričko, Tihana; Žegura, Iva; Skelin, M; Brečić Petrana , T. Jendricko , I. Zegura , M. Skelin and P. BrecicOnline psihoterapija u vrijeme COVID-19: iskustvo profesionalca, 2021. doi:10.1192/j.eurpsy.2021.921 (recenziran, ostalo).
-
14.Jović Zlatović, Josipa; Grubišić-Čabo, Filip; Jajac Bručić, Lana; Skelin, Marko; Budisavljević, Anuška; Telesmanić Dobrić, Vesna; Zubčić Krišto, Slavica; Bilić Knežević, Sara; Curić, Zvonimir; Nalbani, Mario et al.Kliničko iskustvo sigurnosti primjene inhibitora kinaza ovisnih o ciklinima (CDK4/6) u terapiji hormonski pozitivnog Her2 negativnog metastatskog raka dojke: multicentrična, retrospektivna studija 9 nekliničkih onkoloških centara u Republici Hrvatskoj (RH) // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, Volume 143 (2021), Supplement 1; 106-108 (domaća recenzija, kratko priopcenje, znanstveni)
-
15.Javor, Eugen; Allouch, Ali; Osvaldić Galic, Josipa; Skelin, MarkoThe economic impact of a clinical pharmacist’s involvement in the hospital medicines policy in a rural area // International journal of clinical practice, 75 (2021), 11; e14859, 8 doi:10.1111/ijcp.14859 (međunarodna recenzija, članak, znanstveni)
-
16.Javor, Eugen; Skelin, Marko; Lucijanić, MarkoAspirin Dosing in Cardiovascular Disease // The New England journal of medicine, 385 (2021), 8; 764-765 doi:10.1056/NEJMc2110476 (međunarodna recenzija, članak, znanstveni)
-
17.Javor, Eugen; Lucijanić, Marko; Skelin, MarkoOnce-Weekly Semaglutide in Adults with Overweight or Obesity // New England Journal of Medicine, 385 (2021), 1; 4-4 doi:10.1056/nejmc2106918 (međunarodna recenzija, pismo, znanstveni)
-
18.Suton, Petar; Skelin, Marko; Lukšić, IvicaDe-escalation in HPV-associated oropharyngeal cancer: lessons learned from the past? A critical viewpoint and proposal for future research // European archives of oto-rhino-laryngology, 278 (2021), 4599-4603 doi:10.1007/s00405-021-06686-9 (međunarodna recenzija, članak, znanstveni)
-
19.Lucijanić, Marko; Javor, Eugen; Skelin, MarkoColchicine in Patients with Chronic Coronary Disease // The New England journal of medicine, 384 (2021), 8; 777-778 doi:10.1056/NEJMc2034992 (međunarodna recenzija, članak, znanstveni)
-
20.Skelin, Marko; Rahelić, Dario; Skelin, Petar; Lucijanic, MarkoComment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912–1920 // Diabetes Care, 43 (2020), 2; e28-e29 doi:10.2337/dc19-2039 (međunarodna recenzija, pismo uredniku, znanstveni)
-
21.Biganzoli, Laura; Cardoso, Fatima; Beishon, Marc; Cameron, David; Cataliotti, Luigi; Coles, Charlotte E.; Delgado Bolton, Roberto C.; Trill, Maria Die; Erdem, Sema; Fjell, Maria et al.The requirements of a specialist breast centre // The Breast, 51 (2020), 65-84 doi:10.1016/j.breast.2020.02.003 (međunarodna recenzija, članak, znanstveni)
-
22.Lucijanic, Marko; Skelin, Marko; Jurin, Ivana; Hadzibegovic, IrzalOn interactions between body mass index, type of anticoagulation and outcomes // International Journal of Cardiology, 312 (2020), 107-107 doi:10.1016/j.ijcard.2020.04.064 (međunarodna recenzija, pismo uredniku, znanstveni)
-
23.Lucijanic, Marko; Lovrinov, Miran; Skelin, MarkoIron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes // Annals of Internal Medicine, 173 (2020), 7; 595-595 doi:10.7326/l20-1055 (međunarodna recenzija, pismo uredniku, znanstveni)
-
24.Katić, Josip; Mirat, Jure; Rahelić, Dario; Avelini Perković, Ružica; Katić, Karla; Katić, Ana; Skelin, MarkoDabigatran use associated with hemopericardium and hemothorax // Collegium antropologicum, 44 (2020), 3; 155-158 doi:10.5671/ca.44.3.7 (međunarodna recenzija, članak, znanstveni)
-
25.Javor, Eugen; Lucijanić, Marko; Skelin, MarkoDietary Supplement Use and Patient Outcomes in High- Risk Early-Stage Breast Cancer // Journal of clinical oncology, 38 (2020), 18; 2110-2110 doi:10.1200/JCO.20.00091 (međunarodna recenzija, pismo, znanstveni)
-
26.Rahelić, Dario; Matić , Tomas; Skelin, Marko; Klobučar Majanović, Sanja; Bakula, Miro; Deškin, Marin; Bjelinski, Igor; Jurišić Eržen, Dubravka; Krnić, Mladen; Tičinović Kurir, Tina et al.Smjernice za osobe sa šećernom bolešću i zdravstvene djelatnike koji skrbe o oboljelima od šećerne bolesti u Republici Hrvatskoj u vrijeme COVID-19 pandemije Radne skupine Hrvatskog društva za dijabetes i bolesti metabolizma Hrvatskoga liječničkog zbora. // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 142 (2020), 85-88 doi:10.26800/LV-142-3-4-14 (domaća recenzija, pregledni rad, znanstveni)
-
27.Lucijanic, Marko; Jurin, Ivana; Jurin, Hrvoje; Lucijanic, Tomo; Starcevic, Boris; Skelin, Marko; Glasnovic, Anton; Catic, Jasmina; Jurisic, Andjela; Hadzibegovic, IrzalPatients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes // International Journal of Cardiology, 301 (2020), 90-95 doi:10.1016/j.ijcard.2019.10.035 (međunarodna recenzija, članak, ostalo)
-
28.Skelin, Marko; Javor, Eugen; Lucijanic, MarkoAssociation of Early Palliative Care With Survival in Patients With Advanced Lung Cancer // JAMA oncology, 6 (2020), 3; 310-310 doi:10.1001/jamaoncol.2019.6295 (međunarodna recenzija, pismo uredniku, znanstveni)
-
29.Skelin, Marko; Lucijanić, Marko; Javor, EugenThe possible role of insulin and glucagon in patients with heart failure and Type 2 diabetes // European heart journal, 41 (2020), 2; 325-325 doi:10.1093/eurheartj/ehz242 (međunarodna recenzija, pismo uredniku, znanstveni)
-
30.Lucijanic, M.; Jurin, I.; Jurin, H.; Starcevic, B.; Skelin, M.; Glasnovic, A.; Hadzibegovic, I.PATIENTS WITH HIGHER BODY MASS INDEX TREATED WITH DIRECT / NON VITAMIN K DEPENDENT ANTICOAGULANTS (DOAC / NOAC) EXPERIENCE WORSE CLINICAL OUTCOMES // HemaSphere, 3 (2019), S1; 122-122 doi:10.1097/01.hs9.0000559572.74207.d4 (međunarodna recenzija, ostalo, znanstveni)
-
31.Suton, P.; Skelin, M.; Luksic, I.Radiotherapy plus cisplatin (CDDP) or cetuximab (C225) in human papilloma-virus (HPV)- associated oropharyngeal cancer (OPC)? A dilemma finally resolved. An updated meta- analysis // Annals of Oncology, 30 (2019), 5; v457-v457 doi:10.1093/annonc/mdz252.017 (međunarodna recenzija, ostalo, znanstveni)
-
32.Skelin, Marko; Lucijanic, Marko; Lucijanic, JelenaDyslipidaemia, a factor worthy of adjustment // European Journal of Heart Failure, 22 (2019), 3; 564-564 doi:10.1002/ejhf.1647 (međunarodna recenzija, pismo uredniku, znanstveni)
-
33.Javor, Eugen; Skelin, Marko; Lucijanić, MarkoLiraglutide in Children and Teens with Type 2 Diabetes // The New England journal of medicine, 381 (2019), 18; 1786-1787 doi:10.1056/NEJMc1912498 (međunarodna recenzija, pismo uredniku, znanstveni)
-
34.Skelin, Marko; Lucijanić, MarkoLonger survival with anti–programmed cell death 1 and development of cutaneous toxic effects, an expected association // JAMA oncology, 5 (2019), 11; 1642-1642 doi:10.1001/jamaoncol.2019.3808 (međunarodna recenzija, pismo uredniku, znanstveni)
-
35.Krnić, Mladen; Marolt, Iris; Skelin, Marko; Grulović, Natasa; Rahelić, DarioAn observational, multicentre study on different insulin glargine U100 titration algorithms used in patients with type 2 diabetes in daily medical practice in Adriatic countries: The ADRESA study // Diabetes research and clinical practice, 150 (2019), 144-149 doi:10.1016/j.diabres.2019.01.001 (međunarodna recenzija, članak, znanstveni)
-
36.Lucijanic, Marko; Skelin, MarkoPlatelet Counts and Risk of Major Bleeding With Ibrutinib // Clinical Lymphoma Myeloma & Leukemia, 19 (2019), 7; e399-e399 doi:10.1016/j.clml.2019.04.001 (međunarodna recenzija, pismo uredniku, znanstveni)
-
37.Skelin, Marko; Lucijanić, Marko; Miketić, TanjaAbove What Age Should Ibrutinib Not Be Given With R-CHOP to Patients With Non-GBC DLBCL? // Journal of clinical oncology, 37 (2019), 28; 2583-2585 doi:10.1200/jco.19.01048 (međunarodna recenzija, pismo uredniku, znanstveni)
-
38.Lucijanić, Marko; Skelin, Marko; Kušec, RajkoSecond primary malignancies in myeloproliferative neoplasms and the role of aspirin // Leukemia, 33 (2019), 10; 2554-2554 doi:10.1038/s41375-019-0553-2 (međunarodna recenzija, pismo uredniku, znanstveni)
-
39.Lucijanić, Marko; Skelin, Marko; Skelin, PetarCatheter ablation compared with drug therapy for atrial fibrillation // JAMA. Journal of the American Medical Association, 322 (2019), 11; 1105-1105 doi:10.1001/jama.2019.10680 (međunarodna recenzija, pismo uredniku, znanstveni)
-
40.Suton, Petar; Skelin, Marko; Rakušić, Zoran; Dokuzović, Stjepan; Lukšić, IvicaIn reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De- ESCALaTE // European archives of oto-rhino-laryngology, 276 (2019), 7; 2113-2114 doi:10.1007/s00405-019-05485-7 (međunarodna recenzija, pismo uredniku, znanstveni)
-
41.Suton, Petar; Skelin, Marko; Rakušić, Zoran; Dokuzović, Stjepan; Lukšić, IvicaCisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE // European archives of oto-rhino-laryngology, 276 (2019), 5; 1275-1281 doi:10.1007/s00405-019-05387-8 (međunarodna recenzija, članak, znanstveni)
-
42.Skelin, Marko; Javor, Eugen; Lucijanić, MarkoAspirin Use and the Risk of Cancer // JAMA oncology, 5 (2019), 6; 912-913 doi:10.1001/jamaoncol.2019.0611 (međunarodna recenzija, pismo uredniku, znanstveni)
-
43.Skelin, Marko; Javor, EugenValue Based Pharmacy: Developing Qualitative Parameters for Drugs and Public Procurement. // Proceedings Book for 4th ECOP (European Conference of Oncology Pharmacy) 25–27 October 2018, Nantes, France
Nantes, Francuska, 2018. (predavanje, međunarodna recenzija, neobjavljeni rad, znanstveni) -
44.Lucijanić, Marko; Čičić, David; Štoos‑Veić, Tajana; Pejša, Vlatko; Lucijanić, Jelena; Fazlić Džankić, Amina; VLasac Glasnović, Josipa; Sorić, Ena; Skelin, Marko; Kušec, RajkoElevated Neutrophil–to–Lymphocyte-ratio and Platelet–to–Lymphocyte Ratio in Myelofibrosis: Inflammatory Biomarkers or Representatives of Myeloproliferation Itself? // Anticancer Research, 38 (2018), 5; 3157-3163 doi:10.21873/anticanres.12579 (međunarodna recenzija, članak, znanstveni)
-
45.Javor, Eugen; Jakupović, Lejsa; Skelin, MarkoHormone receptor expression and ribociclib activity in hormone receptor positive, human epidermal growth factor receptor 2 negative breast cancer // Libri oncologici : Croatian journal of oncology, 46 (2018), 1; 36-40 doi:.org/10.20471/LO.2018.46.01.06 (domaća recenzija, članak, znanstveni)
-
46.Skelin, Marko; Javor, Eugen; Lucijanić, Marko; Lucijanić, Tomo; Jakupović, Lejsa; Rahelić, DarioThe role of glucagon in the possible mechanism of cardiovascular mortality reduction in type 2 diabetes patients // International journal of clinical practice, 72 (2018), 12; e13274-e13274 doi:10.1111/ijcp.13274 (međunarodna recenzija, članak, znanstveni)
-
47.Skelin, Marko; Lucijanić, Marko; Javor, EugenRisk stratification according to insulin type // European journal of heart failure, 20 (2018), 10; 1497-1497 doi:.org/10.1002/ejhf.1287 (međunarodna recenzija, pismo uredniku, znanstveni)
-
48.Skelin, Marko; Lucijanić, Tomo; Liberati-Čizmek, Ana-Marija; Klobučar Majanović, Sanja; Lucijanić, Marko; Jakupović, Lejsa; Bakula, Miro; Vučak Lončar, Jelena; Marušić, Srečko; Matić, Tomas et al.Effect of timing of levothyroxine administration on the treatment of hypothyroidism : a three- period crossover randomized study // Endocrine (Basingstoke), 62 (2018), 2; 432-439 doi:10.1007/s12020-018-1686-1 (međunarodna recenzija, članak, znanstveni)
-
49.Lucijanić, Marko; Veletić, Ivo; Rahelić, Dario; Pejša, Vlatko; Čičić, David; Skelin, Marko; Livun, Ana; Tupek, Katarina Marija; Štoos-Veić, Tajana; Lucijanic, Tomo et al.Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis // Wiener klinische Wochenschrift, 130 (2018), 3/4; 126-133 doi:10.1007/s00508-018-1318-z (međunarodna recenzija, članak, znanstveni)
-
50.Lucijanic, Marko; Skelin, Marko; Lucijanic, TomoSurvival analysis, more than meets the eye // Biochemia Medica: The journal of The Croatian Society of Medical Biochemistry and Laboratory Medicine, 27 (2017), 14-18 doi:10.11613/bm.2017.002 (međunarodna recenzija, pregledni rad, znanstveni)
-
51.Skelin, Marko; Lucijanić, Tomo; Amidžić Klarić, Daniela; Rešić, Arnes; Bakula, Miro; Liberati- Čizmek, Ana-Marija; Gharib, Hossein; Rahelić, DarioFactors affecting gastrointestinal absorption of levothyroxine : A review // Clinical therapeutics, 39 (2017), 2; 378-403 doi:10.1016/j.clinthera.2017.01.005 (međunarodna recenzija, pregledni rad, znanstveni)
-
52.Rahelić, Dario; Javor, Eugen; Lucijanić, Tomo; Skelin, MarkoEffects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus : a new perspective on sodium–glucose co-transporter 2 inhibitors // Annals of medicine, 49 (2017), 1; 51-62 doi:10.1080/07853890.2016.1226514 (međunarodna recenzija, pregledni rad, znanstveni)
-
53.Skelin, Marko; Javor, Eugen; Pavlica, Vesna; Pavela, Ljubica; Matković, Marina; Šeparović, RobertEffect of statin therapy on cancer incidence // Endocrine oncology and metabolism, 2 (2016), 4; 250-257 doi:10.21040/eom/2016.2.4.2 (međunarodna recenzija, članak, znanstveni)
-
54.Skelin, MarkoSaharoza i manitol kao krioprotektori pri liofilizaciji kitozansko-lecitinskih nanočestica, 2009., diplomski rad, diplomski, Farmaceutsko-biokemijski fakultet, Zagreb
